Kura Oncology, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
KURA chart
What traders are saying about $KURA
Latest postsKura Oncology, Inc. news
- UBS keeps USD 15 target for Kura Oncology stock
ad-hoc-news.de ·
- Kura Oncology, Inc. (KURA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Will Kura Oncology (KURA) Report Negative Q3 Earnings? What You Should Know
Yahoo Finance ·
- How Kura Oncology Inc. (KURA) Affects Rotational Strategy Timing
Stock Traders Daily ·
- Form 144 KURA ONCOLOGY For: 25 October By Investing.com
Investing.com India ·
- Barclays sets a USD 24.00 target for Kura Oncology stock
ad-hoc-news.de ·
- Kura Oncology, Inc. Estimates – NASDAQ:KURA
TradingView ·
- Kura Oncology launches clinical study for farnesyl transferase inhibitor combination therapy
Traders Union ·
- Kura Oncology stock: Kura Oncology sets October 29 results date for Kura Oncology stock
ad-hoc-news.de ·
- Kura Oncology Launches $50M-Backed Diabetes Venture for Oral Menin Inhibitor
marketbeat.com ·
- Caspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in Diabetes
Yahoo Finance ·
- Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes
Yahoo Finance ·
Kura Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $67.5M | $53.9M | $0 | – |
| Net income | -$278.7M | -$174.0M | -$152.6M | -$135.8M |
| Diluted EPS | $-3.18 | $-2.02 | $-2.08 | $-2.03 |
| Total assets (year end) | $738.4M | $760.2M | $448.9M | $456.3M |
| Cash and equivalents (year end) | $149.1M | $224.5M | $37.3M | $51.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Kura Oncology, Inc.
- Ticker
- KURA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1422143
- Former names
- ZETA ACQUISITION CORP III
Frequently asked questions
What exchange is Kura Oncology, Inc. listed on?
Kura Oncology, Inc. trades on the Nasdaq under the ticker symbol KURA.
What industry is Kura Oncology, Inc. in?
Kura Oncology, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Kura Oncology, Inc. headquartered?
Kura Oncology, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Kura Oncology, Inc.'s fiscal year end?
Kura Oncology, Inc.'s fiscal year ends on December 31.
How much revenue did Kura Oncology, Inc. report?
Kura Oncology, Inc. reported $67.5M in revenue for calendar year 2025, according to its SEC filings.